Kallyope Stock
Kallyope is a biotechnology company focused on harnessing the gut-brain axis to develop innovative therapies for various health conditions. Kallyope aims to unlock the complex interactions between metabolic, neurological, and gastrointestinal systems to create effective treatments for diseases such as obesity, diabetes, and neurological disorders.
Sign up for SecondMarket™ to view the market and buy or sell Kallyope Stock
Buy + SellKallyope Funding
Sign up to gain insights into Kallyope funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Feb 15, 2022 | Series D | 236.00M | ||
| Mar 18, 2020 | Series C | 112.50M | ||
| Dec 05, 2018 | Series B | 20.76M | ||
| Feb 22, 2018 | Series B | 66.15M | ||
| Oct 27, 2016 | Series A | 16.00M | ||
| Sep 30, 2015 | Series A | 12.05M |
See Kallyope Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Kallyope Stock Valuation + Share Prices
View real-time Tape D™ data on Kallyope stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Kallyope Management Team
Chief Marketing Officer
Amanda Cole
Chief Commercial Officer
Mark Myers
Director
Peter Hecht
Director
Fritz Lanman
Co-Founder, Solution Architect
Diego Netto
Co-founder, CEO, Director
Ross Lipson
Director
Scott Tobin
COO
Jason Snodgress
Director
Phil Venables
Director
Enrique Salem
Director
Kevin Diestel
Director
Hemant Taneja
Director
Mamoon Hamid
Director
Jerry Chen
Kallyope Major Investors
Column Group
Hartford HealthCare Endowment
DNS Capital, LLC
Greenspring Associates, Inc
DNS Capital, LLC
Illumina, Inc.
Casdin Capital
Parkwood LLC
Alexandria Venture Investments
Euclidean Capital
Illumina, Inc.
Tao Capital Partners
Greenspring Associates, Inc
Mubadala Investment Company
StepStone Group LLC
Two Sigma Ventures
Lux Capital
Polaris Partners
Learn More About Kallyope Stock
Buy Kallyope Stock
01Kallyope stock does not trade on public stock exchanges. Kallyope stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Kallyope stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Kallyope Stock
02Kallyope Stock does not trade on public stock exchanges. In order to sell Kallyope shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Kallyope Stock Price
03Kallyope does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Kallyope share price and other valuable private market data.
Read more about secondary market private company stock prices:
Kallyope Stock Ticker Symbol
04There is no ticker symbol for Kallyope stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Kallyope Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kallyope stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Kallyope Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Kallyope stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Kallyope Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Kallyope IPO
08Kallyope is a private company and has not had an IPO. There is currently no Kallyope IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Kallyope IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Kallyope Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
